About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04839133

Robotic-assisted Exercise Training in Heart Failure

Background: Regular physical activity is an evidence-based adjuvant therapy of chronic heart failure or chronic lung diseases. Structured exercise training is safe, increases exercise capacity and qu...

Lead sponsor: German Heart Institute•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

German Heart Institute

Collaborators

ETH Zurich

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\>17 years old
•written informed consent
•chronic end-stage systolic heart failure without ventricular assist device, LVEF ≤ 45% OR chronic advanced pulmonary diseases
•clinically stable for at least 6 weeks
•ability to mobilize into standing and walking of at least 10 meters with or without rollator
•ability to get up from a chair without rotating the upper body \>45° sagittally

Exclusion Criteria

•addictions or other illnesses that impact the ability to understand the nature, scope and consequences of the trial
•lack of knowledge of German to fully understand study information
•pregnancy, pre-menopausal women
•contraindications of cardiopulmonary exercising
•BMI \> 35 kg/m², waist size \> 135 cm.
•Height \<150 cm, \>195 cm
•Weight\<45 kg, \>110 kg
•Functional Reach Test \<15,24 cm
•Flexion contracture in the knee/hip joint \>10°
•Chronic colonization or active infection with multi-resistant pathogens

Related studies

Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation

RECRUITINGPhase 2

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

NCT07646587 · COPD (Chronic Obstructive Pulmonary Disease)

Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany

NCT06675552 · Heart Disease, Heart Failure, and more

Innate Immunity in COPD

NCT05743582 · Chronic Obstructive Pulmonary Disease

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

NCT07190222 · Chronic Obstructive Pulmonary Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 24, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment30

Start dateMar 2021

Last updatedNov 24, 2021

Condition

Heart Failure, Systolic Pulmonary Disease

Locations shown

German Heart Center

Berlin

German Heart Institute

Berlin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 24, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions